Please use this identifier to cite or link to this item:
Title: Rare presentation of isolated bilateral testicular myeloid sarcoma: A case report.
Austin Authors: Thomson, Alice;Timm, Brennan ;Nazaretian, Simon;Liodakis, Peter ;Bolton, Damien M 
Affiliation: Urology
North Eastern Urology, Heidelberg, Victoria, Australia
Clinical Director Anatomical Pathology VIC/SA, Australian Clinical Labs, Australia
Issue Date: May-2021 2021
Publication information: Urology Case Reports 2021; online first: 28 January
Abstract: Myeloid sarcoma (MS) of the testis is a rare soft tissue tumour which can herald the development of acute myeloid leukaemia (AML). The diagnosis of MS requires a high degree of suspicion as appropriate immunohistochemical staining must be performed to yield an early diagnosis. Whilst there is no consensus on treatment on MS involving the testis, most patients undergo orchidectomy and systemic chemotherapy, with or without radiation therapy. Early and aggressive treatment is key to achieving remission. This case report describes a patient with bilateral testicular MS which heralded the development of AML, who underwent induction chemotherapy and achieved remission.
DOI: 10.1016/j.eucr.2021.101585
PubMed URL: 33552919
ISSN: 2214-4420
Type: Journal Article
Subjects: Acute myeloid leukaemia
Case report
Myeloid sarcoma
Testicular neoplasms
Appears in Collections:Journal articles

Files in This Item:
3 files
File Description SizeFormat 
25860.pdf6.37 MBAdobe PDF
Download Adobe
Show full item record

Page view(s)

checked on Jun 19, 2021


checked on Jun 19, 2021

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.